Seeking Alpha

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025

Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD) PFM improved inorganic pyrophosphate ...
Business Insider

Rectify Pharma Announces Positive Functional Modulator RTY-694 as Development Candidate for Primary Sclerosing Cholangitis

RTY-694 is a potent, orally active ABCB4/BSEP positive functional modulator (PFM) that improves bile composition and enhances bile flow The differentiated mechanism of a dual-targeted ABCB4/BSEP PFM ...
MedCity News

Atlas Venture-incubated Rectify lands $100M to transport drug hunt to new grounds

One of the quirks about drug hunting is that finding new medicines doesn’t always mean uncovering something completely new. Sometimes it’s about revisiting previously hunted grounds and spotting ...
C&EN

Rectify launches with $100 million to drug ABC transporters

Rectify Pharmaceuticals has launched with $100 million in series A financing to develop drugs that restore the function of ATP-binding cassette (ABC) transporters. ABC transporters are membrane-bound ...